PubRank

A J Jenkins

Author PubWeight™ 36.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996 2.42
2 Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia 2010 1.88
3 Sweat testing for heroin, cocaine, and metabolites. J Anal Toxicol 1994 1.86
4 Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J 1997 1.48
5 A DNA fragment containing the groE genes can suppress mutations in the Escherichia coli dnaA gene. Mol Gen Genet 1986 1.41
6 Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol Dial Transplant 1996 1.24
7 Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine. J Biol Chem 2000 1.15
8 Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women. Diabetologia 2008 1.00
9 Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo. J Biol Chem 1997 1.00
10 Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness. Diabet Med 2006 0.98
11 The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Diabetologia 2007 0.94
12 Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes. Diabetologia 2006 0.94
13 Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin. J Anal Toxicol 2001 0.90
14 Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus. Intern Med J 2006 0.89
15 Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells. J Appl Physiol (1985) 2001 0.89
16 Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Diabet Med 2012 0.87
17 NMR-determined lipoprotein subclass profile is associated with dietary composition and body size. Nutr Metab Cardiovasc Dis 2010 0.84
18 Novel versus traditional risk markers for diabetic retinopathy. Diabetologia 2011 0.84
19 Increased tissue kallikrein levels in type 2 diabetes. Diabetologia 2010 0.84
20 Elevated plasma prostaglandins and acetylated histone in monocytes in Type 1 diabetes patients. Diabet Med 2009 0.84
21 Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy. Atherosclerosis 2006 0.83
22 Aminoguanidine and the effects of modified LDL on cultured retinal capillary cells. Invest Ophthalmol Vis Sci 2000 0.83
23 Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles. Atherosclerosis 2008 0.82
24 Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patients. Diabetes Obes Metab 2010 0.82
25 Loxapine intoxication: case report and literature review. J Anal Toxicol 2000 0.81
26 Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. Diabet Med 2014 0.81
27 A fentanyl epidemic in Maryland 1992. J Forensic Sci 1994 0.80
28 Isotope dilution gas chromatography/mass spectrometry method for the determination of methionine sulfoxide in protein. Anal Chem 2001 0.79
29 Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration. J Anal Toxicol 2000 0.79
30 Lipoprotein glycation and its metabolic consequences. Curr Opin Lipidol 1997 0.79
31 Quantification of N-(glucitol)ethanolamine and N-(carboxymethyl)serine: two products of nonenzymatic modification of aminophospholipids formed in vivo. Anal Biochem 1999 0.78
32 Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes. BJOG 2012 0.77
33 Distribution of venlafaxine in three postmortem cases. J Anal Toxicol 1996 0.77
34 Plasma low-molecular weight fluorescence in type 1 diabetes mellitus. Ann N Y Acad Sci 2005 0.77
35 Octreotide treatment of severe diabetic diarrhoea. Intern Med J 2003 0.76
36 Tissue distribution of olanzapine in a postmortem case. Am J Forensic Med Pathol 2001 0.76
37 Acute intoxication with guaifenesin, diphenhydramine, and chlorpheniramine. Am J Forensic Med Pathol 1999 0.75
38 Evaluation of an onsite alcohol testing device for use in postmortem forensic toxicology. J Anal Toxicol 2001 0.75
39 6-acetylmorphine detection in postmortem cerebrospinal fluid. J Anal Toxicol 1998 0.75
40 Pressure support ventilation. Am Fam Physician 1988 0.75
41 Distribution of sertraline in postmortem cases. J Anal Toxicol 1994 0.75
42 Arcuate area of the female rat maintained in vitro exhibits increased afternoon electrical activity. Neuroendocrinology 1989 0.75
43 Laser-Doppler velocimetry and photoplethysmography in the diagnosis of abnormal venous reflux. Phlebologie 1989 0.75
44 Novel agents for managing dyslipidaemia. Expert Opin Investig Drugs 2001 0.75
45 Prosthetic valve endocarditis: what is the evidence for anticoagulant therapy? Intern Med J 2011 0.75
46 Diabetes research in South Carolina: past, present, and future. J S C Med Assoc 1998 0.75
47 Beware frontotemporal dermoids - they may have intracranial extension: a case of a middle cranial fossa cyst. J Plast Reconstr Aesthet Surg 2012 0.75